|
3759
|
(aR)-RP-6306
|
(aR)-enantiomer of RP-6306 (Axon 3668); PKMYT1 inhibitor |
Recently added
|
€180.00 |
|
3821
|
ABT-263
|
Potent, selective and orally bioavailable inhibitor of B-cell lymphoma-2 (BCL-2) family proteins |
Recently added
|
Inquire |
|
3785
|
ABT-639
|
Peripherally acting, selective and orally bioavailable T-type Ca2+ channel blocker |
Recently added
|
€115.00 |
|
3827
|
AMG-511
|
Orally bioavailable, highly potent and selective pan-class I phosphatidylinositol-3 kinase (PI3K) inhibitor |
Recently added
|
Inquire |
|
3682
|
AMZ30
|
Potent, selective and covalent PME-1 inhibitor |
€130.00 |
|
3742
|
Apararenone
|
Potent and highly selective nonsteroidal mineralocorticoid receptor (MR) antagonist |
Recently added
|
€130.00 |
|
2757
|
Asciminib
|
Potent and selective allosteric BCR-ABL1 inhibitor |
Recently added
|
€120.00 |
|
3771
|
AZD2858
|
Potent and highly selective Glycogen Synthase Kinase-3β inhibitor |
Recently added
|
€95.00 |
|
3808
|
AZD3458
|
Orally bioavailable potent and selective PI3Kγ inhibitor |
Recently added
|
Inquire |
|
3814
|
AZD4320
|
BH3-mimetic inhibitor of BCL-2 protein |
Recently added
|
Inquire |
|
3800
|
AZD4573
|
Inhibitor of CDK9 |
Recently added
|
Inquire |
|
3833
|
AZD5153 HNT salt
|
Potent, selective, and orally available BET/BRD4 bromodomain inhibitor |
Recently added
|
Inquire |
|
3778
|
BAY-091
|
First potent and highly selective PIP4K2A inhibitor |
Recently added
|
€180.00 |
|
3598
|
BAY-091 hydrochloride
|
First potent and highly selective PIP4K2A inhibitor |
Recently added
|
€180.00 |
|
3638
|
BAY-179
|
Potent, selective, and species cross-reactive complex I inhibitor |
Recently added
|
€100.00 |
|
3832
|
BAY-1816032
|
Potent and selective BUB1 (Mitotic checkpoint serine/threonine-protein kinase) inhibitor |
Recently added
|
Inquire |
|
3760
|
Belzutifan
|
Second-generation potent, selective and orally active HIF-2α inhibitor |
Recently added
|
€280.00 |
|
3813
|
BMS-911543
|
Potent, selective and orally active inhibitor of JAK2 |
Recently added
|
Inquire |
|
3786
|
BP-1-102
|
Orally bioavailable STAT3 inhibitor |
Recently added
|
€90.00 |
|
3762
|
CDK4-IN-I
|
Orally bioavailable and CDK4-Specific Inhibitor |
Recently added
|
Inquire |
|
3763
|
CFT-7455
|
Orally active monofunctional degrader for IKZF1/3 |
Recently added
|
Inquire |
|
3764
|
CFT-8634
|
Selective orally bioavailable BRD9 degrader |
Recently added
|
Inquire |
|
3736
|
CGS 15943
|
Potent and selective adenosine antagonist |
Recently added
|
€80.00 |
|
3765
|
DS-3032
|
Orally available, potent and selective inhibitor of the p53-MDM2 interaction |
Recently added
|
Inquire |
|
3766
|
DT-2216
|
Selective B-cell lymphoma-extra large (Bcl-XL) targeted protein degrader |
Recently added
|
Inquire |
|
3613
|
EN219
|
Covalent RNF114 ligand |
Recently added
|
€120.00 |
|
3674
|
Ena21 hydrochloride
|
Selective and competitive ALKBH5 inhibitor |
Recently added
|
€110.00 |
|
3769
|
FHD-286
|
Selective inhibitor of the BAF chromatin remodeling complex ATPases (BRG1/BRM) |
Recently added
|
Inquire |
|
3767
|
GDC-1971
|
Orally available, potent, and selective inhibitor of the protein tyrosine phosphatase SHP2 |
Recently added
|
Inquire |
|
3768
|
GDC-6036
|
Inhibitor of KRAS G12C |
Recently added
|
Inquire |